Biopharmaceuticals Neuromuscular Disorders Regulatory Approval Infectious Diseases Biotechnology Revenue Generation Geopolitics Investor Relations Drug Research Pandemic Preparedness
Sarepta is enlisting experts to design a stronger immunosuppressive regimen.